Search

everythinglearnresearchcommunity

for

Search:↓

The new drug delivery system effectively targets lung cancer cells.

A new staining method shows a special area in the hair's skin layer with lots of proteoglycans.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Lead levels in hair increased due to environmental exposure, while iron, copper, and zinc levels stayed stable.

The hydrogel effectively treats dental implant issues by killing bacteria, reducing inflammation, and improving implant success.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Long-pulsed ruby lasers effectively reduce hair for up to 2 years with minimal pain.

The modified osmium method improves hair cortex staining for better visualization.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

PrrH sRNA controls pyochelin production in *Pseudomonas aeruginosa*.

PRP gel is a safe, affordable treatment needing trained staff and proper facilities.

Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.

Reticulocyte hemoglobin content is the best indicator of iron deficiency in women with diffuse non-scarring hair loss.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

DRDE-07 shows promise for treating skin diseases due to its favorable properties.

Moderately lipophilic dyes penetrate skin deeply, while highly hydrophobic or lipophilic dyes stay on the surface.

Rushton's hyaline bodies form from hair keratin and blood substances.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Dual wavelength LEDs may help reduce hair loss by lowering DHT levels.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Red light therapy temporarily increased blood flow in the eye but didn't change other eye structures.